Marshall Urist - May 8, 2025 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
EVP, Research & Investments
Signature
/s/ Sean Weisberg, as Attorney-in-Fact, for Marshall Urist
Stock symbol
RPRX
Transactions as of
May 8, 2025
Transactions value $
$0
Form type
4
Date filed
5/9/2025, 05:07 PM
Previous filing
Aug 12, 2024
Next filing
May 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Urist Marshall EVP, Research & Investments C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK /s/ Sean Weisberg, as Attorney-in-Fact, for Marshall Urist 2025-05-09 0001838139

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $0 +36.5K +78.18% $0.00 83.2K May 8, 2025 Direct F1
holding RPRX Class A Ordinary Shares 19K May 8, 2025 By IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.